Cellebrite DI (CLBT) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Cellebrite DI reported a remarkable third-quarter 2024, achieving a milestone with $106.9 million in revenue, a 27% increase from the previous year driven by subscription growth. The company’s ARR rose to $370.8 million, and they showcased a strong adjusted EBITDA of $31.3 million. This robust performance has led Cellebrite to raise its 2024 revenue and adjusted EBITDA outlook, reflecting positive investor sentiment and market traction.
For further insights into CLBT stock, check out TipRanks’ Stock Analysis page.
